Reproductive Health Matters
Volume 11, Issue 22 , Pages 101-112 , November 2003

Rape and HIV Post-Exposure Prophylaxis: Addressing the Dual Epidemics in South Africa

  • Julia C Kim

      Affiliations

    • Senior Researcher, Rural AIDS and Development Action Research Programme (RADAR), School of Public Health, University of the Witwatersrand, South Africa; Clinical Research Fellow, Health Policy Unit, London School of Hygiene and Tropical Medicine, UK
    • ,
  • Lorna J Martin

      Affiliations

    • Specialist Forensic Pathologist, Division of Forensic Medicine and Toxicology, University of Cape Town, South Africa.
    • ,
  • Lynette Denny

      Affiliations

    • Associate Professor and Senior Specialist, Gynaecology Oncology Unit, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town, South Africa

References 

  1. Comprehensive Report: National STD/HIV/AIDS Review. Pretoria: Medical Research Council, 1997.
  2. UNAIDS . Global report on the AIDS epidemic. Geneva: UNAIDS; 2000;
  3. Williams B, Campbell C. Understanding the epidemic of HIV in South Africa. South African Medical Journal. 1998;88:247–251
  4. Jewkes R, Abrahams N. The epidemiology of rape and sexual coercion in South Africa: an overivew. Social Science and Medicine. 2002;55(7):1231–1244
  5. South African Police Services. SAPS: Provincial crime specific statistics 1994 to 2000. Available from: 〈http://www.saps.org.za/8_crimeinfo/bulletin/942000.htm〉.
  6. International Criminal Police Organisation (ICPO). Interpol International Crime Statistics, 1996.
  7. Garcı́a Moreno C, Watts C. Violence against women: its importance for HIV/AIDS. AIDS. 2000;14(Suppl.3):S253–S265
  8. Heise L, Moore K, Toubia N. Sexual Coercion and Women's Reproductive Health: A Focus on Research. New York: Population Council; 1995;
  9. Vetten L, Bhana K. Violence, vengeance and gender: a preliminary investigation into the links between violence against women and HIV/AIDS in South Africa. Johannesburg: Centre for the Study of Violence and Reconciliation, April 2001.
  10. Cardo DM, Culver DH, Ciesielski CA, et al.  US Centers for Disease Control and Prevention Needlestick Surveillance Group. A case–control study of HIV seroconversion in health care workers after percutaneous exposure. New England Journal of Medicine. 1997;337:1485–1490
  11. US Centers for Disease Control . Case–control study of HIV seroconversion in healthcare workers after percutaneous exposure to HIV-infected blood—France, United Kingdom, and United States, January 1988–August 1994. Morbidity and Mortality Weekly Report. 1995;44:929–933
  12. Black RJ. Animal studies of prophylaxis. American Journal of Medicine. 1997;102:39–44
  13. Watson A, McClure J, Ranchalis J, et al.  Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques. AIDS Research and Human Retroviruses. 1997;13:1375–1381
  14. Connor EM, Sperling RS, Gelber R, et al.  Reduction of maternal–infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine. 1994;331:1173–1180
  15. Wiktor SZ, Ekpini E, Karon JM, et al.  Short course oral zidovudine for prevention of maternal-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet. 1999;353:781–785
  16. Centers for Disease Control and Prevention. US Centers for Disease Control and Prevention Update: PHS Report summarizes current scientific knowledge on the use of post-exposure antiretroviral therapy for non-occupational exposures. September 1998.
  17. Bamberger JD, Waldo CR, Gerberding JL, et al.  Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. American Journal of Medicine. 1999;106(3):323–326
  18. Koh HK, DeMaria A, McGuire JF. Massachusetts Clinical Advisory. Massachusetts, 2001.
  19. Roland M. Prophylaxis following non-occupational exposure to HIV. 2002; At: 〈http://hivinsite.ucsf.edu/〉
  20. Myles J, Bamberger J. Offering HIV prophylaxis following sexual assault: recommendations for the State of California. San Francisco: California HIV PEP after Sexual Assault Task Force in conjunction with the California State Office of AIDS, 2001.
  21. UNAIDS . Global Report on the HIV/AIDS Epidemic. Geneva: UNAIDS; 2002;
  22. Heise L, Ellsberg M, Gottemoeller M. Ending violence against women. Population Reports. 1999;Dec(11):1–43
  23. Heise L, Raikes A, Watts CH, et al.  Violence against women: a neglected public health issue in less developed countries. Social Science and Medicine. 1994;39(4):1165–1179
  24. Crime Information Analysis Centre (CIAC). South African Police Service Crime Statistics. Pretoria, 2000.
  25. Human Rights Watch . Scared at School: Sexual Violence Against Girls in South African Schools. New York: Human Rights Watch; 2001;
  26. Human Sciences Research Council. Nelson Mandela/HSRC Study of HIV/AIDS: South African national HIV prevalence, behavioural risks and mass media. Household Survey. Cape Town: Human Sciences Research Council (HSRC), 2002.
  27. Martin LJ. Violence against women: an analysis of the epidemiology and patterns of injury in rape homicide in Cape Town and in rape in Johannesburg. M Med thesis, University of Cape Town, 1999.
  28. Swart L, Gilchrist A, Butchart A, et al.  Rape surveillance through district surgeon offices in Johannesburg, 1996–1998: findings, evaluation and prevention implications. South African Journal of Psychology. 2000;30(2):1–10
  29. Mokwena S. The era of the jackrollers: contextualising the rise of youth gangs in Soweto. Johannesburg: Centre for Violence and Reconciliation; 1991;
  30. Wood K, Maforah F, Jewkes R. ‘He forced me to love him’: putting violence on adolescent sexual health agendas. Social Science and Medicine. 1998;47:233–242
  31. South African Law Commission. Sexual Offences Report. Project 107, 2002.
  32. Department of Health . South Africa Demographic and Health Survey: Final report. Pretoria: Department of Health; 1998;
  33. Artz L. Access to Justice for Rural Women: Special Focus on Violence Against Women. Cape Town: Institute of Criminology, University of Cape Town; 1999;
  34. Human Rights Watch . Human Rights Watch Report: Violence Against Women in South Africa. New York: Human Rights Watch; 1995;
  35. CIET Africa . Prevention of sexual violence. A social audit of the role of the police in the jurisdiction of Johannesburg's Southern Metropolitan Local Council. Johannesburg: CIET Africa; 1998;
  36. Masimanyane Women's Support Centre. Violence Against Women. An Exploratory Study of the Impact of the Justice System on Victims/Survivors of Domestic Violence and Rape. East London: Masimanyane Women's Support Centre, 1999.
  37. CIET Africa . Prevention of sexual violence: a social audit of the role of the police in the jurisdiction of Johannesburg's Southern Metropolitan Local Council. Johannesburg: CIET Africa; 1998;
  38. Jewkes R, Abrahams N. A review study commissioned by the Crime Prevention Research Resources Centre on violence against women in South Africa: rape and sexual coercion. Pretoria: Crime Prevention Research Resources Centre and Medical Research Council, South Africa; 2000;
  39. Martin LJ. Forensic examination model in South Africa. Proceedings of Meeting: Consultation on the Health Sector Response to Sexual Violence. Geneva: World Health Organization; 2001;
  40. Pithey B, Artz L, Combrinck H, et al. Legal aspects of rape: discussion document commissioned by the Deputy Minister of Justice, 1999.
  41. World Health Organization. Guidelines for Medico-Legal Care for Victims of Sexual Violence. Geneva: WHO (Forthcoming).
  42. Martin LJ, Denny L. Standardised provincial guidelines for the management of survivors of rape or sexual assault & Report on Sexual Assault Examination. Western Cape Department of Health; 2000;
  43. Denny L, Martin LJ, Buford L, et al. The challenge of providing PEP to survivors of rape: preliminary analysis of Standard Sexual Assault examination form used at Groote Schuur Hospital and GF Jooste Hospital from 1998 to 2001. In: First South African Gender Based Violence and Health Conference, Johannesburg, 2002.
  44. Centers for Disease Control and Prevention . Management of Possible Sexual, Injecting-Drug-Use or Other Nonoccupational Exposure to HIV, Including Considerations Related to Antiretroviral Therapy: Public Health Service Statement. CDC Morbidity and Mortality Weekly Report. Recommendations and Reports. 1998;47(RR17):1–14
  45. Lawrence O. HIV testing, counseling, and prophylaxis after sexual assault. JAMA. 1994;271(18):1437–1444
  46. Katz MH, Gerberding JL. The care of persons with recent sexual exposure to HIV. Annals of Internal Medicine. 1998;128:306–311
  47. Wiebe ER, Comay SE, McGregor M, et al.  Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service. Canadian Medical Association Journal. 2000;162(5):641–645
  48. DeGrurrola V, et al.  Infectiousness of HIV between male homosexual partners. Journal of Clinical Epidemiology. 1989;42:849–856
  49. Ippolito G, Puro V, De Carli G, et al.  The risk of occupational HIV in health care workers. Archive of Internal Medicine. 1993;153:1451–1458
  50. British Columbia Women's Hospital. Annual Report. Vancouver: BC Women's Hospital–Vancouver General Hospital Sexual Assault Service, 1998.
  51. Slaughter L, et al.  Patterns of genital injury in female sexual assault victims. American Journal of Obstetrics and Gynecology. 1997;176:609–616
  52. Lauber AA, Souma SM. Use of toluidine blue for documentation of traumatic intercourse. Obstetrics and Gynecology. 1982;60:644–648
  53. Jenny C, et al.  Sexually transmitted diseases in victims of rape. New England Journal of Medicine. 1990;322:713–716
  54. Padian NS, et al.  Heterosexual transmission of HIV in northern California: results from a ten-year study. American Journal of Epidemiology. 1997;146(4):350–357
  55. Niu MT, et al.  Primary HIV type-1 infection: review of pathogenesis and early treatment intervention in human and animal retrovirus infections. Journal of Infectious Diseases. 1993;168:1490–1501
  56. Gerberding JL. Management of occupational exposures to blood-borne viruses. New England Journal of Medicine. 1995;332:444–451
  57. Schuler M. Violence against women: an international perspective. In:  Schuler M editors. Freedom from Violence: Women's Strategies from around the World. New York: UNIFEM; 1992;
  58. Katz MH, Gerberding JL. Postexposure treatment of people exposed to the human immunodeficiency virus though sexual contact or injection drug use. New England Journal of Medicine. 1997;336:1097–1100
  59. Launay O, Soussy A, Aubert M. Post-sexual exposure prophylaxis with HAART after sexual assaults. XIIIth International AIDS Conference. Abstract WePeC4313. Durban, 9–14 July 2000.
  60. Roland ME, Krone MR, Neilands TB, et al. HIV seroconversion following non-occupational post-exposure prophylaxis. Presented at: National HIV Prevention Conference; Atlanta, GA, 2003.
  61. Kahn JO, Martin JN, Roland ME, et al.  Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study. Journal of Infectious Diseases. 2001;183:707–714
  62. Pronyk PM, Kim JC, Porter J. Whose priorities? A response to the issue of antiretrovirals in Africa. Tropical Medicine and International Health. 2001;6(8):575–578

PII: S0968-8080(03)02285-7

doi: 10.1016/S0968-8080(03)02285-7

Reproductive Health Matters
Volume 11, Issue 22 , Pages 101-112 , November 2003

Article Tools